Carla J. DeMuro-Mercon

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Filter by Publication Topic

Search Results

Longitudinal trajectories of participant- and study partner-rated cognitive decline, in relation to Alzheimer’s disease biomarkers and mood symptoms

Patients' experiences in transitioning to secondary progressive multiple sclerosis: Qualitative interviews

Use of patient and investigator global impression scales: A review of food and drug administration-approved labeling, 2009 to 2019

Psychometric evaluation of the Nocturia Sleep Quality Scale based on data from a prospective observational study

Self-reported review of the value of esketamine in patients with treatment-resistant depression: Understanding the patient experience in the STRIVE Study

Analysis of clinical trial exit interview data in patients with treatment-resistant depression

Development of the Nocturia Sleep Quality Scale: A patient-reported outcome measure of sleep impact related to nocturia

Development, psychometric evaluation, and initial feasibility assessment of a symptom tracker for use by patients with heart failure (HFaST)

Development of a novel observer-reported outcome measure for the assessment of Respiratory Syncytial Virus (RSV) infection symptoms in pediatric clinical trials

A review of patient-reported outcomes labeling for oncology drugs approved by the FDA and the EMA (2012-2016)

Conducting patient interviews within a clinical trial setting

Psychometric evaluation of a caregiver diary for the assessment of symptoms of respiratory syncytial virus

A review of patient-reported outcome labeling in the United States (2011-2015)

Payer perspectives on patient-reported outcomes in health care decision making: Oncology examples

Development of the Observable Behaviors of Autism Spectrum Disorder Scale

A review of patient-reported outcome labeling in the United States (2011–2015)

Psychometric evaluation of the sporadic inclusion body myositis (sIBM) physical functioning assessment (sIFA)

Psychometric evaluation of the Sheehan Disability Scale in adult patients with attention deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment.

Assessment of PRO label claims granted by the FDA as compared to the EMA (2006–2010)

Role of Patient-Reported Outcome Measures in the Assessment of Central Nervous System Agents